{"id":"https://openalex.org/W59842216","doi":null,"title":"Aripiprazole, alcohol and substance abuse: a review.","display_name":"Aripiprazole, alcohol and substance abuse: a review.","publication_year":2012,"publication_date":"2012-10-01","ids":{"openalex":"https://openalex.org/W59842216","mag":"59842216","pmid":"https://pubmed.ncbi.nlm.nih.gov/23104650"},"language":"en","primary_location":{"id":"pmid:23104650","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23104650","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European review for medical and pharmacological sciences","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068790726","display_name":"Marcella Brunetti","orcid":"https://orcid.org/0000-0003-2413-6861","observed_orcids":["https://orcid.org/0000-0003-2413-6861"]},"institutions":[{"id":"https://openalex.org/I39387349","display_name":"University of Chieti-Pescara","ror":"https://ror.org/00qjgza05","country_code":"IT","type":"education","lineage":["https://openalex.org/I39387349"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M Brunetti","raw_affiliation_strings":["Institute of Advanced Biomedical Technologies, University of Chieti, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Advanced Biomedical Technologies, University of Chieti, Italy","institution_ids":["https://openalex.org/I39387349"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087178986","display_name":"L. Di Tizio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Di Tizio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030051711","display_name":"S. Dezi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Dezi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072483598","display_name":"Gino Pozzi","orcid":"https://orcid.org/0000-0001-5227-7974","observed_orcids":["https://orcid.org/0000-0001-5227-7974"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Pozzi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077293585","display_name":"Paolo Grandinetti","orcid":"https://orcid.org/0000-0003-2015-3648","observed_orcids":["https://orcid.org/0000-0003-2015-3648"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Grandinetti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5070312407","display_name":"Giovanni Martinotti","orcid":"https://orcid.org/0000-0002-7292-2341","observed_orcids":["https://orcid.org/0000-0002-7292-2341"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Martinotti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.2139,"has_fulltext":false,"cited_by_count":48,"citation_normalized_percentile":{"value":0.91084816,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"16","issue":"10","first_page":"1346","last_page":"54"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.7289999723434448,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.7289999723434448,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.2151000052690506,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.04820000007748604,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aripiprazole","display_name":"aripiprazole","score":1.0},{"id":"https://openalex.org/keywords/substance-abuse","display_name":"substance abuse","score":0.7260000109672546},{"id":"https://openalex.org/keywords/alcoholism","display_name":"alcoholism","score":0.7699999809265137},{"id":"https://openalex.org/keywords/cocaine-dependence","display_name":"cocaine dependence","score":0.7900000214576721},{"id":"https://openalex.org/keywords/amphetamine-use-disorder","display_name":"amphetamine use disorder","score":0.9879999756813049},{"id":"https://openalex.org/keywords/nicotine-dependence","display_name":"nicotine dependence","score":0.9589999914169312},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":0.7689999938011169},{"id":"https://openalex.org/keywords/5-ht1a-receptor","display_name":"5-HT1A receptor","score":0.9480000138282776},{"id":"https://openalex.org/keywords/5-ht2a-receptor","display_name":"5-HT2A receptor","score":0.8450000286102295},{"id":"https://openalex.org/keywords/dopamine-agonists","display_name":"dopamine agonists","score":0.6060000061988831},{"id":"https://openalex.org/keywords/dopaminergic-neurotransmission","display_name":"dopamine signaling","score":0.7310000061988831},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.7870000004768372},{"id":"https://openalex.org/keywords/addiction-treatment","display_name":"addiction treatment","score":0.6629999876022339}],"concepts":[{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.945723831653595},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.7659997344017029},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5636064410209656},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.48337382078170776},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.477979838848114},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.47738713026046753},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.4706175625324249},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.44830620288848877},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.44315558671951294},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.4232706129550934},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.4192027747631073},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41471990942955017},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.378093957901001},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.23314252495765686},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18473216891288757},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.17039793729782104},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.13427159190177917},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.11104223132133484}],"mesh":[{"descriptor_ui":"D000068180","descriptor_name":"Aripiprazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000437","descriptor_name":"Alcoholism","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014029","descriptor_name":"Tobacco Use Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019970","descriptor_name":"Cocaine-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:23104650","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23104650","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European review for medical and pharmacological sciences","raw_type":"Journal Article"},{"id":"mag:59842216","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23104650","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":65,"referenced_works":["https://openalex.org/W76449867","https://openalex.org/W1705421561","https://openalex.org/W1747110054","https://openalex.org/W1963849023","https://openalex.org/W1964151041","https://openalex.org/W1966483710","https://openalex.org/W1967339016","https://openalex.org/W1973905875","https://openalex.org/W1978434699","https://openalex.org/W1978717814","https://openalex.org/W1980277133","https://openalex.org/W1999482407","https://openalex.org/W2006821655","https://openalex.org/W2010282456","https://openalex.org/W2010890416","https://openalex.org/W2015006945","https://openalex.org/W2015046028","https://openalex.org/W2015162971","https://openalex.org/W2025053184","https://openalex.org/W2027018469","https://openalex.org/W2028780766","https://openalex.org/W2031654719","https://openalex.org/W2032552670","https://openalex.org/W2033608262","https://openalex.org/W2037102395","https://openalex.org/W2039094176","https://openalex.org/W2040942076","https://openalex.org/W2046280658","https://openalex.org/W2050247926","https://openalex.org/W2050340461","https://openalex.org/W2052587611","https://openalex.org/W2055363801","https://openalex.org/W2059215761","https://openalex.org/W2061060151","https://openalex.org/W2061159066","https://openalex.org/W2062550341","https://openalex.org/W2062576181","https://openalex.org/W2068904330","https://openalex.org/W2070357412","https://openalex.org/W2072952515","https://openalex.org/W2074115024","https://openalex.org/W2076879478","https://openalex.org/W2079044695","https://openalex.org/W2079715253","https://openalex.org/W2084115967","https://openalex.org/W2085073153","https://openalex.org/W2086175717","https://openalex.org/W2095870441","https://openalex.org/W2104853779","https://openalex.org/W2107200746","https://openalex.org/W2112089058","https://openalex.org/W2117052590","https://openalex.org/W2118301953","https://openalex.org/W2118856873","https://openalex.org/W2127772114","https://openalex.org/W2142363976","https://openalex.org/W2146648200","https://openalex.org/W2149056696","https://openalex.org/W2156639688","https://openalex.org/W2164386461","https://openalex.org/W2170979974","https://openalex.org/W2214185525","https://openalex.org/W2405516362","https://openalex.org/W2526506579","https://openalex.org/W2619521118"],"related_works":["https://openalex.org/W1967339016","https://openalex.org/W2068904330","https://openalex.org/W1983958548","https://openalex.org/W137025916","https://openalex.org/W2339758256","https://openalex.org/W2004252407","https://openalex.org/W2921477620","https://openalex.org/W2050247926","https://openalex.org/W2031654719","https://openalex.org/W4412075905"],"abstract_inverted_index":{"Aripiprazole":[0],"is":[1],"an":[2,39],"atypical":[3],"antipsychotic":[4],"used":[5],"for":[6,21,80,98,183],"schizophrenia,":[7],"manic":[8],"and":[9,17,34,37,62,71,126,156,188],"mixed":[10],"episodes":[11],"associated":[12],"with":[13],"bipolar":[14],"I":[15],"disorder":[16],"as":[18,27,38,94],"adjunctive":[19],"therapy":[20],"major":[22],"depressive":[23],"disorder.":[24],"It":[25],"functions":[26],"a":[28,77,95,164],"partial":[29,72],"agonist":[30],"at":[31,41],"dopamine":[32,73,82],"D2":[33],"5-HT1A":[35],"receptors,":[36],"antagonist":[40],"the":[42,87,99,130,143,148,157,162,168,181],"5-HT2A":[43],"receptor.":[44],"The":[45,67],"most":[46],"recent":[47,112],"results":[48],"obtained":[49],"from":[50],"scientific":[51,113],"research":[52,114],"showed":[53],"that":[54],"dopaminergic":[55],"mechanisms":[56],"are":[57],"involved":[58],"in":[59,86,117,172],"motivation,":[60],"reward,":[61],"reinforcement":[63],"of":[64,69,101,104,132,146,151,161,170],"substance":[65,105,119],"abuse.":[66],"use":[68,169],"aripiprazole":[70,93,116,133,171],"agonists":[74],"could":[75],"represent":[76],"novel":[78],"strategy":[79],"normalizing":[81],"neurotransmission.":[83],"Many":[84],"studies":[85],"last":[88],"few":[89],"years":[90],"have":[91],"highlighted":[92],"potential":[96],"candidate":[97],"treatment":[100],"different":[102,118],"types":[103],"dependence.":[106],"This":[107],"review":[108],"aims":[109],"to":[110,135],"describe":[111],"using":[115],"abuse":[120],"disorders":[121],"(i.e.,":[122],"alcoholism,":[123],"cocaine,":[124],"amphetamine":[125],"nicotine":[127],"use).":[128],"Furthermore,":[129],"efficacy":[131],"compared":[134],"other":[136],"pharmacological":[137],"therapies":[138],"will":[139],"be":[140,176],"described.":[141],"Given":[142],"low":[144,158],"number":[145],"studies,":[147,163,185],"frequent":[149],"absence":[150],"placebo":[152],"or":[153],"active":[154],"comparators,":[155],"statistical":[159],"power":[160],"clear":[165],"conclusion":[166],"about":[167],"alcohol/substance":[173],"dependence":[174],"cannot":[175],"drawn.":[177],"Therefore,":[178],"we":[179],"suggest":[180],"need":[182],"further":[184],"preferably":[186],"randomized":[187],"placebo-controlled.":[189]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}